AzTrials
AzTrials

Blood Pressure ManagementHEARTNCT06845514

Impact of Resistance Training Intensity on Blood Pressure

A study testing Condition LL-RE and Condition HL-RE in people with Blood Pressure Management and Blood Pressure Monitoring, Ambulatory, run by Université de Sherbrooke at 1 site in Canada.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of the clinical trial is to understand the effect of two resistance training protocols employing different loading intensities (% of 1 repetition maximum; 1-RM), but with standardized effort intensity (2 repetitions in reserve; RIR) on post-exercise and ambulatory blood pressure in aging females. Read more about this study

Who is it for?
Ages 50 to 70 years, women onlyHealthy volunteers can take part
What is being tested?
Condition LL-RE and Condition HL-RE
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteCanada
Study dates
8 Jul 2025to Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 70 years
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • aged 50 to 70 years;
  • absence of menstruation for 12 consecutive months;
  • normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 < Diastolic ≤ 99 mmHg);
  • physically inactive (< 150 minutes of structured aerobic physical activity per week);
  • and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year.

Who cannot join

  • orthopedic limitations or other contraindications to resistance exercise;
  • scheduled surgery during the study;
  • unstable hypertension (≥ 160/100 mmHg);
  • diagnosis of type 2 diabetes;
  • cardiovascular event in the past 6 months or sequelae preventing exercise;
  • and initiation of hormonal replacement therapy (< 4 months) known to affect blood pressure.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Canada1 site, 1 recruiting
  • Research Center on Aging

    Sherbrooke, Quebec, J1H 2J7

    Eléonor Riesco, Ph.D., 819-821-8000 ext. 63337, e.riesco@usherbrooke.ca

    Recruiting

Other trials in Canada

About this study

Official title: High Blood Pressure and Effect of Acute Resistance Training: Influence of Different Load Intensities on Postexercise Hypotension and Ambulatory Blood Pressure in Aging Females

The goal of the clinical trial is to understand the effect of two resistance training protocols employing different loading intensities (% of 1 repetition maximum; 1-RM), but with standardized effort intensity (2 repetitions in reserve; RIR) on post-exercise and ambulatory blood pressure in aging females.

The main questions it aims to answer are:

Read more
  • to examine the acute effects of low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise with a standardized high effort intensity on post-exercise hypotension and ambulatory blood pressure responses in aging females;
  • deepen the understanding of the mechanisms underlying acute reductions in blood pressure in response to resistance exercise performed at different load intensities. To this end, autonomic activity will be estimated alongside the measurement of central arterial compliance (i.e., carotid artery), and serum biomarkers of endothelial function;
  • document the affective valence and enjoyment associated with low (50% 1-RM) and high (80% 1-RM) load intensity resistance exercise when performed at a high perceived effort.

Researchers will compare the effect of: 1) a low load (LL-RE) intensity protocol consisting of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 2) high load (HL-RE) intensity protocol consisting of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2); 3) and a control condition (CON) consisting of a standardized non-fatiguing cognitive task.

Participants will participate in:

  • A preliminary assessment visit;
  • Two familiarization visits to validate the exercise prescriptions;
  • Three experimental visits (CON, LL-RE, HL-RE).
Read the detailed description

Significant inconsistencies in the literature have led to resistance exercise often being overlooked as a method for managing high blood pressure and hypertension. The method of prescribing resistance exercise, whether it is based on load intensity (i.e., % of one-repetition maximum [1-RM]), perceived effort intensity (i.e., using a perception scale), or a combination of both, likely contributes to these inconsistencies. However, for inactive older adults, a growing number of studies suggest that lifting low loads (< 60% 1-RM) with high effort intensity, close to or until momentary muscle failure, is a promising approach for various health outcomes. However, it remains to be determined if this approach is acceptable and effective for blood pressure control. Moreover, there is a growing body of evidence suggesting marked sex differences in the acute and chronic blood pressure responses to resistance exercise, with women potentially benefiting more from low load intensity. This is particularly important because it has been reported that postmenopausal women achieve less adequate blood pressure control than men. Researchers propose to explore the effects of low-intensity resistance exercise (50% 1-RM) performed with high perceived effort intensity on post-exercise hypotension, known for its association with the long-term benefits of resistance training, and ambulatory blood pressure in postmenopausal women. Given that high-intensity load resistance training (≥ 75-80% 1-RM) is currently suggested and associated with chronic reductions in resting systolic blood pressure, researchers will also test whether this potential difference remains at a high load intensity (80% 1-RM) with high perceived effort intensity. These hypotheses will be tested while exploring the mechanisms related to post-exercise hypotension, taking into account enjoyment and affective valence, two important factors related to long-term exercise adherence.

Objective #1 (Primary): Examine the acute effects of low-intensity (50% 1-RM) and high-intensity (80% 1-RM) resistance exercise with standardized effort intensity (2 repetitions in reserve; [RIR]) on post-exercise hypotension and ambulatory blood pressure responses in aging women with normal-high resting blood pressure or hypertension.

Objective #2 (Secondary): Deepen the understanding of the underlying mechanisms of acute blood pressure reductions in response to resistance exercise performed at different load intensities. To this end, autonomic activity will be estimated alongside the measurement of central arterial compliance and serum biomarkers of endothelial function.

Objective #3 (Secondary): Document the affective valence and pleasure associated with low-intensity (50% 1-RM) and high-intensity (80% 1-RM) resistance exercise performed at high perceived effort.

A randomized crossover study including three experimental conditions will be conducted: CON, LL-RE (50% 1-RM), and HL-RE (80% 1-RM). A total of 36 women will be recruited according to these inclusion criteria: aged 50 to 70 years, absence of menstruation for 12 consecutive months, normal-high resting blood pressure (120 ≤ Systolic ≤ 139 mmHg and 80 ≤ Diastolic ≤ 89 mmHg) or stage 1 hypertension (140 ≤ Systolic ≤ 159 mmHg or 90 < Diastolic ≤ 99 mmHg), physically inactive (< 150 minutes of structured aerobic physical activity per week), and not engaging in regular resistance exercise (≥ 2 sessions per week) for more than 3 months during the year. Exclusion criteria include: orthopedic limitations or other contraindications to resistance exercise, scheduled surgery during the study, unstable hypertension (≥ 160/100 mmHg), diagnosis of type 2 diabetes, cardiovascular event in the past 6 months or sequelae preventing exercise, and initiation of hormonal replacement therapy (< 4 months) known to affect blood pressure. Eligible participants will be invited to the research center for a preliminary visit, and the following variables will be collected: resting heart rate, resting blood pressure, fasting metabolic profile, body composition, socio-demographic data, medical history, physical activity habits (questionnaires), and 1-RM tests to estimate the load to be used during experimental conditions. In the following two weeks (maximum), a familiarization period will take place, consisting of 2 sessions to familiarize participants with the exercises and the concept of perceived effort during this type of training. The experimental period will then begin with ≥ 72 hours between the 3 visits. During each experimental condition, blood pressure and heart rate variability will be assessed before and after the training session at regular intervals (every 20 minutes for 60 minutes), and ambulatory over 24 hours (non-dominant arm, every 20 minutes during the day and every 30 minutes at night). Blood samples and ultrasound measurements of carotid arterial compliance will also be collected before, immediately after the experimental portion (exercise), and 60 minutes later. In the 12 hours preceding the experimental conditions, participants must refrain from consuming caffeine and alcohol and limit moderate to vigorous physical activity. In the 24 hours following the experimental conditions, muscle soreness, food intake, and physical activity level will be assessed.

This study will be the first to determine if there are differences in the acute blood pressure responses to different load intensities during resistance exercises with a standardized effort intensity, a key variable in the prescription of resistance exercises for various health outcomes. The results will directly contribute to the existing knowledge on the impact of resistance exercise on blood pressure control in females, while taking into account patient-reported outcomes (affective valence and pleasure). These perspectives can provide valuable guidance to researchers and policymakers when evaluating the feasibility of implementing such an approach in clinical practice. Consequently, the results will help update exercise recommendations for blood pressure management and offer insights into the potential mechanisms responsible for hypotension.

Being tested
Condition LL-RE, Control, Condition HL-RE
Keywords
resistance training, ambulatory blood pressure, aging females, load intensity, perceived effort
Medical subject headings
Hypertension

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Condition LL-REOther

    LL-RE condition will consist of a 5-minute warm-up (slow-paced walking) and the following exercises: leg press, chest press, leg curl, and seated row. Three sets will be performed for each exercise with a 3-minute rest period between sets/exercises. Each exercise will be executed through a full range of motion, with participants encouraged to follow a 2-sec eccentric phase (guided by a mobile app metronome and supervised by an exercise physiologist) and to perform the concentric phase as fast as possible. Participants will be informed to: stop the set when they perceive to have reached the RIR target.

    • LL-RE: The low load intensity protocol consists of 3 sets of each exercise at 50% 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2).
  • ControlOther

    Control condition: During the control condition, participants will sit quietly in a room maintained at a temperature of 22-24°C to prevent any influence on blood pressure values, for 60 minutes. During this period, they will perform a standardized non-fatiguing cognitive task: watching Earth, a documentary following the migration paths of four animal families.

  • Condition HL-REOther

    HL-RE condition will consist of a 5-minute warm-up (slow-paced walking) and the following exercises: leg press, chest press, leg curl, and seated row. Three sets will be performed for each exercise with a 3-minute rest period between sets/exercises. Each exercise will be executed through a full range of motion, with participants encouraged to follow a 2-sec eccentric phase (guided by a mobile app metronome and supervised by an exercise physiologist) and to perform the concentric phase as fast as possible. Participants will be informed to: stop the set when they perceive to have reached the RIR target.

    • HL-RE: The high load intensity protocol consists of 3 sets of each exercise at 80% of 1-RM, performed until reaching a hard perceived effort intensity (i.e., RIR-2).
Study groups in NCT06845514
Study groupRoleWhat they receive
Condition LL-REExperimentalLow-load resistance exercise
Receives: Other: Condition LL-RE
Condition HL-REExperimentalHigh-load resistance exercise
Receives: Other: Condition HL-RE
Condition CONSham comparatorControl condition
Receives: Other: Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in blood pressure post-exercise

    Oscillometric blood pressure monitor

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), each 20 min for 1 hour post-condition (t = 80, 100, 120 minutes)

  2. Change in ambulatory blood pressure

    Ambulatory blood pressure monitor

    Measured: During 24 hours after the condition

Secondary outcomes (10)
  1. Heart rate variability

    Heart rate monitor

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), each 20 min for 1 hour post-condition (t = 80, 100, 120 minutes), during 24 hours after the condition

  2. Carotid artery diameter as assessed by Cardiovascular Suite v4.6.1

    Doppler ultrasound

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  3. Carotid artery distensibility as assessed by Cardiovascular Suite v4.6.1

    Doppler ultrasound

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  4. Carotid artery blood flow velocity

    Doppler ultrasound

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  5. Serum endothelin-1

    Enzyme-Linked Immunosorbent Assay

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  6. Serum endothelial nitric oxide synthase

    Enzyme-Linked Immunosorbent Assay

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  7. Serum catecholamines

    Enzyme-Linked Immunosorbent Assay

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  8. Salivary cortisol

    Enzyme-Linked Immunosorbent Assay

    Measured: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), 1 hour post-condition (t = 120 minutes)

  9. Affective valence

    Valence Scale (-5, +5). Higher values are related to higher affective valence.

    Measured: Before the start of the condition (t = 0 minute), during the condition (t = 30 minutes), at the end of the condition (t = 60 minutes)

  10. Enjoyment

    Physical Activity Enjoyment Scale (16, 80 points). Higher values are related to higher enjoyment.

    Measured: At the end of the condition (t = 60 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Feb 2025
  2. Study start8 Jul 2025
  3. Primary completionMay 2028 (estimated)
  4. Study completionDec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Each participant will perform 3 experimental conditions (control condition; low-load resistance exercise; high-load resistance exercise).
Masking
None (open label)
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06845514
Sponsor's protocol ID
2025-5649
Acronym
HEART
Status last verified
Feb 2025
First submitted
12 Feb 2025
Last updated
9 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Condition LL-RE and Condition HL-RE in people with Blood Pressure Management and Blood Pressure Monitoring, Ambulatory, run by Université de Sherbrooke at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 9 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Eléonor Riesco, Ph.D. (819-821-8000 ext. 63337, e.riesco@usherbrooke.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in blood pressure post-exercise (time frame: Before the start of the condition (t = 0 minute), at the end of the condition (t = 60 minutes), each 20 min for 1 hour post-condition (t = 80, 100, 120 minutes)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in